Arecor Therapeutics plc (LON:AREC – Get Free Report) shares traded down 7.8% on Friday . The stock traded as low as GBX 64.50 ($0.81) and last traded at GBX 70.50 ($0.89). 18,864 shares were traded during mid-day trading, an increase of 37% from the average session volume of 13,806 shares. The stock had previously closed at GBX 76.50 ($0.97).
Arecor Therapeutics Stock Down 7.8 %
The firm has a fifty day moving average price of GBX 74.06 and a 200-day moving average price of GBX 90.60. The firm has a market cap of £26.62 million, a price-to-earnings ratio of -251.79 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- What is a Death Cross in Stocks?
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Market Cap Calculator: How to Calculate Market Cap
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Healthcare Dividend Stocks to Buy
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
